Fig. 1

Study flow chart. Clinical outcomes were compared among 17 patients on HD with ACS due to ST (ST-ACS with HD), 170 non-HD patients with ACS due to ST (ST-ACS without HD), 246 patients on HD with ACS due to de novo coronary artery lesions (de novo-ACS with HD), and 1,610 non-HD patients with ACS due to de novo coronary artery lesions (de novo-ACS without HD). ACS, acute coronary syndrome; HD, hemodialysis; MACE, major adverse cardiac events; PCI, percutaneous coronary intervention; ST, stent thrombosis.